Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy.

Parkinsonism & related disorders - 1 Dec 2007

Abdo W F, van de Warrenburg B P C, Kremer H P H, Bloem B R, Verbeek M M

Abstract excerpt

BACKGROUND: Multiple system atrophy (MSA) can clinically be divided into the cerebellar (MSA-C) and the parkinsonian (MSA-P) variants. It is unknown whether the variation in clinical expression is also reflected by a different underlying neurochemical profile. METHODS: We analyzed brain specific proteins and neurotransmitter metabolites in cerebrospinal fluid (CSF) of 26 patients with MSA-C and 19 with MSA-P....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers
Share to Cerebellum

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multiple System Atrophy

Share to Neurotransmitter Agents

Share to Parkinsonian Disorders

Share to Phenotype

Source

Identifiers

PMID: 17448720
DOI: 10.1016/j.parkreldis.2007.02.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

CSF biomarker profiles do not differentiate between the cerebellar and parkinsonian phenotypes of multiple system atrophy.PMID 17448720Read ↗

The Many Faces of Parkinsonism: Dissecting Clinical and Molecular Overlap in Multiple System Atrophy and Parkinson's DiseaseSemantic proximity Read ↗

Heterogeneity of Multiple System Atrophy: An UpdateSemantic proximity Read ↗

Difference in MSA phenotype distribution between populations: genetics or environment?Semantic proximity Read ↗

Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.Semantic proximity Read ↗

The DJ-1 concentration in cerebrospinal fluid does not differentiate among parkinsonian syndromesSemantic proximity Read ↗

The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations.Semantic proximity Read ↗

MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson’s Disease and Multiple System AtrophySemantic proximity Read ↗

MSA-C is the predominant clinical phenotype of MSA in Japan: analysis of 142 patients with probable MSA.Semantic proximity Read ↗

Does the Type of Multisystem Atrophy, Parkinsonism, or Cerebellar Ataxia Impact on the Nature of Sleep Disorders?Semantic proximity Read ↗

CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian DisordersSemantic proximity Read ↗

Probable multiple system atrophy in a German family.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.